Acorda Therapeutics Has Returned 33.4% Since SmarTrend Recommendation (ACOR)
June 09, 2017 at 14:30 PM EDT
SmarTrend identified a Downtrend for Acorda Therapeutics (NASDAQ:ACOR) on March 24th, 2017 at $25.35. In approximately 3 months, Acorda Therapeutics has returned 33.35% as of today's recent price of...